Whitepaper: 340B Program Compliance

February 1, 2024

Access whitepaper

The Patient Definition, Eligibility & Required Documentation

This white paper provides an overview of the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) 340B Drug Discount Pricing Program with a particular focus on aspects of legislation and regulation that impact patient definition and referral prescriptions.

Features in-depth analysis of patient definition by describing:

  • HHS and Apexus positions with respect to patient and provider eligibility.
  • Current and historical guidelines on patient definition with an emphasis on referral prescriptions.
  • An exclusive data analysis from eight 340B covered entity (CE) contract pharmacies and vendor partners revealing overall referral prescription capture rate at 2% and specialty capture nearly absent.
  • Operational and technical challenges involved in capturing referral prescriptions in a manner that satisfies HRSA audits.
  • How 340B Recovery solves current challenges.

Subscribe to our email list to get the latest in your inbox